Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: NOVARTIS PHARMACEUTICALS CANADA INC
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02339501 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR | Human | Yes | Prescription | 1 | EVEROLIMUS | 5 MG |
Marketed | 02339528 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR | Human | Yes | Prescription | 1 | EVEROLIMUS | 10 MG |
Marketed | 02369257 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR | Human | Yes | Prescription | 1 | EVEROLIMUS | 2.5 MG |
Cancelled Post Market | 02450267 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR | Human | Yes | Prescription | 1 | EVEROLIMUS | 7.5 MG |
Marketed | 02425645 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR DISPERZ | Human | Yes | Prescription | 1 | EVEROLIMUS | 2 MG |
Marketed | 02425653 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR DISPERZ | Human | Yes | Prescription | 1 | EVEROLIMUS | 3 MG |
Marketed | 02425661 | NOVARTIS PHARMACEUTICALS CANADA INC | AFINITOR DISPERZ | Human | Yes | Prescription | 1 | EVEROLIMUS | 5 MG |
Approved | 02479605 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Prescription | 1 | ERENUMAB | 70 MG / ML |
Approved | 02479605 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Schedule D | 1 | ERENUMAB | 70 MG / ML |
Marketed | 02479613 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Schedule D | 1 | ERENUMAB | 70 MG / ML |
Marketed | 02479613 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Prescription | 1 | ERENUMAB | 70 MG / ML |
Approved | 02487292 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Schedule D | 1 | ERENUMAB | 140 MG / ML |
Approved | 02487292 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Prescription | 1 | ERENUMAB | 140 MG / ML |
Marketed | 02487306 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Prescription | 1 | ERENUMAB | 140 MG / ML |
Marketed | 02487306 | NOVARTIS PHARMACEUTICALS CANADA INC | AIMOVIG | Human | Yes | Schedule D | 1 | ERENUMAB | 140 MG / ML |
Marketed | 00893560 | NOVARTIS PHARMACEUTICALS CANADA INC | ALOMIDE | Human | Yes | Prescription | 1 | LODOXAMIDE (LODOXAMIDE TROMETHAMINE) | 0.1 % / W/V |
Cancelled Post Market | 00010510 | NOVARTIS PHARMACEUTICALS CANADA INC | ANTURAN 100MG | Human | No | Prescription | 1 | SULFINPYRAZONE | 100 MG / TAB |
Cancelled Post Market | 00010529 | NOVARTIS PHARMACEUTICALS CANADA INC | ANTURAN 200MG | Human | No | Prescription | 1 | SULFINPYRAZONE | 200 MG / TAB |
Cancelled Post Market | 02059770 | NOVARTIS PHARMACEUTICALS CANADA INC | AREDIA | Human | Yes | Prescription | 1 | PAMIDRONATE DISODIUM | 60 MG / VIAL |
Cancelled Post Market | 02059762 | NOVARTIS PHARMACEUTICALS CANADA INC | AREDIA 30MG | Human | Yes | Prescription | 1 | PAMIDRONATE DISODIUM | 30 MG / VIAL |
Cancelled Post Market | 02059789 | NOVARTIS PHARMACEUTICALS CANADA INC | AREDIA 90MG | Human | Yes | Prescription | 1 | PAMIDRONATE DISODIUM | 90 MG / VIAL |
Cancelled Post Market | 02381559 | NOVARTIS PHARMACEUTICALS CANADA INC | ARZERRA | Human | Yes | Schedule D | 1 | OFATUMUMAB | 100 MG / 5 ML |
Cancelled Post Market | 02381559 | NOVARTIS PHARMACEUTICALS CANADA INC | ARZERRA | Human | Yes | Prescription | 1 | OFATUMUMAB | 100 MG / 5 ML |
Cancelled Post Market | 02381567 | NOVARTIS PHARMACEUTICALS CANADA INC | ARZERRA | Human | Yes | Schedule D | 1 | OFATUMUMAB | 1000 MG / 50 ML |
Cancelled Post Market | 02381567 | NOVARTIS PHARMACEUTICALS CANADA INC | ARZERRA | Human | Yes | Prescription | 1 | OFATUMUMAB | 1000 MG / 50 ML |
Marketed | 02498685 | NOVARTIS PHARMACEUTICALS CANADA INC | ATECTURA BREEZHALER | Human | Yes | Prescription | 2 | INDACATEROL (INDACATEROL ACETATE) | 150 MCG |
Marketed | 02498693 | NOVARTIS PHARMACEUTICALS CANADA INC | ATECTURA BREEZHALER | Human | Yes | Prescription | 2 | INDACATEROL (INDACATEROL ACETATE) | 150 MCG |
Marketed | 02498707 | NOVARTIS PHARMACEUTICALS CANADA INC | ATECTURA BREEZHALER | Human | Yes | Prescription | 2 | INDACATEROL (INDACATEROL ACETATE) | 150 MCG |
Marketed | 02331624 | NOVARTIS PHARMACEUTICALS CANADA INC | AZARGA | Human | Yes | Prescription | 2 | TIMOLOL (TIMOLOL MALEATE) | 0.5 % / W/V |
Marketed | 02238873 | NOVARTIS PHARMACEUTICALS CANADA INC | AZOPT | Human | Yes | Prescription | 1 | BRINZOLAMIDE | 1 % / W/V |
Marketed | 02496976 | NOVARTIS PHARMACEUTICALS CANADA INC | BEOVU | Human | Yes | Prescription | 1 | BROLUCIZUMAB | 6 MG / 0.05 ML |
Approved | 02496984 | NOVARTIS PHARMACEUTICALS CANADA INC | BEOVU | Human | Yes | Prescription | 1 | BROLUCIZUMAB | 6 MG / 0.05 ML |
Approved | 02496984 | NOVARTIS PHARMACEUTICALS CANADA INC | BEOVU | Human | Yes | Schedule D | 1 | BROLUCIZUMAB | 6 MG / 0.05 ML |
Marketed | 01908448 | NOVARTIS PHARMACEUTICALS CANADA INC | BETOPTIC S | Human | Yes | Prescription | 1 | BETAXOLOL (BETAXOLOL HYDROCHLORIDE) | 0.25 % / W/V |
Cancelled Post Market | 00176214 | NOVARTIS PHARMACEUTICALS CANADA INC | CAFERGOT PB SUP | Human | No | Schedule G (CDSA IV) | 4 | ERGOTAMINE (ERGOTAMINE TARTRATE) | 2 MG / SUP |
Cancelled Post Market | 00176222 | NOVARTIS PHARMACEUTICALS CANADA INC | CAFERGOT PB TAB | Human | No | Schedule G (CDSA IV) | 4 | PENTOBARBITAL SODIUM | 30 MG / TAB |
Cancelled Post Market | 00782920 | NOVARTIS PHARMACEUTICALS CANADA INC | CAFERGOT SUP | Human | Yes | Prescription | 2 | ERGOTAMINE TARTRATE | 2 MG / SUP |
Cancelled Post Market | 00176095 | NOVARTIS PHARMACEUTICALS CANADA INC | CAFERGOT TAB | Human | Yes | Prescription | 2 | ERGOTAMINE TARTRATE | 1 MG |
Approved | 02375907 | NOVARTIS PHARMACEUTICALS CANADA INC | CERTICAN | Human | Yes | Prescription | 1 | EVEROLIMUS | 0.25 MG |
Approved | 02375915 | NOVARTIS PHARMACEUTICALS CANADA INC | CERTICAN | Human | Yes | Prescription | 1 | EVEROLIMUS | 0.5 MG |
Approved | 02375923 | NOVARTIS PHARMACEUTICALS CANADA INC | CERTICAN | Human | Yes | Prescription | 1 | EVEROLIMUS | 0.75 MG |
Marketed | 01945270 | NOVARTIS PHARMACEUTICALS CANADA INC | CILOXAN | Human | Yes | Prescription | 1 | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) | 0.3 % / W/V |
Marketed | 02200864 | NOVARTIS PHARMACEUTICALS CANADA INC | CILOXAN | Human | Yes | Prescription | 1 | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) | 0.3 % / W/W |
Marketed | 02252716 | NOVARTIS PHARMACEUTICALS CANADA INC | CIPRODEX | Human | Yes | Prescription | 2 | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) | 0.3 % / W/V |
Approved | 02438062 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Prescription | 1 | SECUKINUMAB | 150 MG / ML |
Approved | 02438062 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Schedule D | 1 | SECUKINUMAB | 150 MG / ML |
Marketed | 02438070 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Schedule D | 1 | SECUKINUMAB | 150 MG / ML |
Marketed | 02438070 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Prescription | 1 | SECUKINUMAB | 150 MG / ML |
Marketed | 02525569 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Prescription | 1 | SECUKINUMAB | 75 MG / 0.5 ML |
Marketed | 02525569 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Schedule D | 1 | SECUKINUMAB | 75 MG / 0.5 ML |
Approved | 02529653 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Schedule D | 1 | SECUKINUMAB | 300 MG / 2 ML |
Approved | 02529653 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Prescription | 1 | SECUKINUMAB | 300 MG / 2 ML |
Approved | 02529661 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Prescription | 1 | SECUKINUMAB | 300 MG / 2 ML |
Approved | 02529661 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Schedule D | 1 | SECUKINUMAB | 300 MG / 2 ML |
Approved | 02547724 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Prescription | 1 | SECUKINUMAB | 150 MG / ML |
Approved | 02547724 | NOVARTIS PHARMACEUTICALS CANADA INC | COSENTYX | Human | Yes | Schedule D | 1 | SECUKINUMAB | 150 MG / ML |
Cancelled Post Market | 00587729 | NOVARTIS PHARMACEUTICALS CANADA INC | CYTADREN TAB 250MG | Human | No | Prescription | 1 | AMINOGLUTETHIMIDE | 250 MG / TAB |
Cancelled Post Market | 01981250 | NOVARTIS PHARMACEUTICALS CANADA INC | DESFERAL 2G | Human | Yes | Prescription | 1 | DEFEROXAMINE MESYLATE | 2 G / VIAL |
Marketed | 01981242 | NOVARTIS PHARMACEUTICALS CANADA INC | DESFERAL 500MG | Human | Yes | Prescription | 1 | DEFEROXAMINE MESYLATE | 500 MG / VIAL |
Marketed | 02270528 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN | Human | Yes | Prescription | 1 | VALSARTAN | 40 MG |
Marketed | 02289504 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN | Human | Yes | Prescription | 1 | VALSARTAN | 320 MG |
Cancelled Post Market | 02236809 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN 160MG | Human | No | Prescription | 1 | VALSARTAN | 160 MG |
Marketed | 02244782 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN 160MG TABLETS | Human | Yes | Prescription | 1 | VALSARTAN | 160 MG |
Cancelled Post Market | 02236808 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN 80MG | Human | No | Prescription | 1 | VALSARTAN | 80 MG |
Marketed | 02244781 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN 80MG TABLETS | Human | Yes | Prescription | 1 | VALSARTAN | 80 MG |
Marketed | 02241900 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN-HCT | Human | Yes | Prescription | 2 | VALSARTAN | 80 MG |
Marketed | 02241901 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN-HCT | Human | Yes | Prescription | 2 | VALSARTAN | 160 MG |
Marketed | 02246955 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN-HCT | Human | Yes | Prescription | 2 | VALSARTAN | 160 MG |
Marketed | 02308908 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN-HCT | Human | Yes | Prescription | 2 | VALSARTAN | 320 MG |
Marketed | 02308916 | NOVARTIS PHARMACEUTICALS CANADA INC | DIOVAN-HCT | Human | Yes | Prescription | 2 | VALSARTAN | 320 MG |
Marketed | 02278251 | NOVARTIS PHARMACEUTICALS CANADA INC | DUOTRAV PQ | Human | Yes | Prescription | 2 | TRAVOPROST | 0.004 % / W/V |
Marketed | 02415534 | NOVARTIS PHARMACEUTICALS CANADA INC | DUREZOL | Human | Yes | Prescription | 1 | DIFLUPREDNATE | 0.05 % / W/V |
Marketed | 02501244 | NOVARTIS PHARMACEUTICALS CANADA INC | ENERZAIR BREEZHALER | Human | Yes | Prescription | 3 | INDACATEROL (INDACATEROL ACETATE) | 150 MCG |
Marketed | 02446928 | NOVARTIS PHARMACEUTICALS CANADA INC | ENTRESTO | Human | Yes | Prescription | 2 | VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) | 26 MG |
Marketed | 02446936 | NOVARTIS PHARMACEUTICALS CANADA INC | ENTRESTO | Human | Yes | Prescription | 2 | VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) | 51 MG |
Marketed | 02446944 | NOVARTIS PHARMACEUTICALS CANADA INC | ENTRESTO | Human | Yes | Prescription | 2 | VALSARTAN (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) | 103 MG |
Cancelled Post Market | 02243529 | NOVARTIS PHARMACEUTICALS CANADA INC | ESTALIS SEQUI | Human | Yes | Prescription | 3 | ESTRADIOL | 0.62 MG |
Cancelled Post Market | 02243530 | NOVARTIS PHARMACEUTICALS CANADA INC | ESTALIS SEQUI | Human | Yes | Prescription | 3 | ESTRADIOL | 0.51 MG |
Cancelled Post Market | 02108186 | NOVARTIS PHARMACEUTICALS CANADA INC | ESTRACOMB | Human | Yes | Prescription | 3 | ESTRADIOL | 4 MG |
Cancelled Post Market | 00756792 | NOVARTIS PHARMACEUTICALS CANADA INC | ESTRADERM-100 | Human | Yes | Prescription | 1 | ESTRADIOL | 8 MG |
Cancelled Post Market | 00756849 | NOVARTIS PHARMACEUTICALS CANADA INC | ESTRADERM-25 | Human | Yes | Prescription | 1 | ESTRADIOL | 2 MG |
Cancelled Post Market | 00756857 | NOVARTIS PHARMACEUTICALS CANADA INC | ESTRADERM-50 | Human | Yes | Prescription | 1 | ESTRADIOL | 4 MG / STRIP |
Marketed | 02287420 | NOVARTIS PHARMACEUTICALS CANADA INC | EXJADE | Human | Yes | Prescription | 1 | DEFERASIROX | 125 MG |
Marketed | 02287439 | NOVARTIS PHARMACEUTICALS CANADA INC | EXJADE | Human | Yes | Prescription | 1 | DEFERASIROX | 250 MG |
Marketed | 02287447 | NOVARTIS PHARMACEUTICALS CANADA INC | EXJADE | Human | Yes | Prescription | 1 | DEFERASIROX | 500 MG |
Cancelled Post Market | 02337819 | NOVARTIS PHARMACEUTICALS CANADA INC | EXTAVIA | Human | Yes | Prescription | 1 | INTERFERON BETA-1B | 0.3 MG / VIAL |
Cancelled Post Market | 02337819 | NOVARTIS PHARMACEUTICALS CANADA INC | EXTAVIA | Human | Yes | Schedule D | 1 | INTERFERON BETA-1B | 0.3 MG / VIAL |
Marketed | 02231384 | NOVARTIS PHARMACEUTICALS CANADA INC | FEMARA | Human | Yes | Prescription | 1 | LETROZOLE | 2.5 MG |
Cancelled Post Market | 00275328 | NOVARTIS PHARMACEUTICALS CANADA INC | FIORINAL TAB | Human | No | Schedule G (CDSA IV) | 3 | BUTALBITAL | 50 MG |
Marketed | 00756784 | NOVARTIS PHARMACEUTICALS CANADA INC | FLAREX | Human | Yes | Prescription | 1 | FLUOROMETHOLONE ACETATE | 0.1 % / W/V |
Cancelled Post Market | 02230898 | NOVARTIS PHARMACEUTICALS CANADA INC | FORADIL DRY POWDER CAPSULES FOR INHALATION | Human | Yes | Prescription | 1 | FORMOTEROL FUMARATE | 12 MCG |
Marketed | 02365480 | NOVARTIS PHARMACEUTICALS CANADA INC | GILENYA | Human | Yes | Prescription | 1 | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) | 0.5 MG |
Marketed | 02482533 | NOVARTIS PHARMACEUTICALS CANADA INC | GILENYA | Human | Yes | Prescription | 1 | FINGOLIMOD (FINGOLIMOD HYDROCHLORIDE) | 0.25 MG |
Cancelled Post Market | 02244725 | NOVARTIS PHARMACEUTICALS CANADA INC | GLEEVEC | Human | Yes | Prescription | 1 | IMATINIB (IMATINIB MESYLATE) | 100 MG |
Marketed | 02253275 | NOVARTIS PHARMACEUTICALS CANADA INC | GLEEVEC | Human | Yes | Prescription | 1 | IMATINIB (IMATINIB MESYLATE) | 100 MG |
Marketed | 02253283 | NOVARTIS PHARMACEUTICALS CANADA INC | GLEEVEC | Human | Yes | Prescription | 1 | IMATINIB (IMATINIB MESYLATE) | 400 MG |
Cancelled Post Market | 02231116 | NOVARTIS PHARMACEUTICALS CANADA INC | HYCAMTIN | Human | Yes | Prescription | 1 | TOPOTECAN (TOPOTECAN HYDROCHLORIDE) | 4 MG / VIAL |
Cancelled Post Market | 00010413 | NOVARTIS PHARMACEUTICALS CANADA INC | HYGROTON 50MG | Human | No | Prescription | 1 | CHLORTHALIDONE | 50 MG |
Cancelled Post Market | 02344939 | NOVARTIS PHARMACEUTICALS CANADA INC | ILARIS | Human | Yes | Prescription | 1 | CANAKINUMAB | 150 MG / VIAL |
Cancelled Post Market | 02344939 | NOVARTIS PHARMACEUTICALS CANADA INC | ILARIS | Human | Yes | Schedule D | 1 | CANAKINUMAB | 150 MG / VIAL |
Marketed | 02460351 | NOVARTIS PHARMACEUTICALS CANADA INC | ILARIS | Human | Yes | Prescription | 1 | CANAKINUMAB | 150 MG / ML |
Marketed | 02460351 | NOVARTIS PHARMACEUTICALS CANADA INC | ILARIS | Human | Yes | Schedule D | 1 | CANAKINUMAB | 150 MG / ML |
Marketed | 02411393 | NOVARTIS PHARMACEUTICALS CANADA INC | ILEVRO | Human | Yes | Prescription | 1 | NEPAFENAC | 0.3 % / W/V |
Cancelled Post Market | 00000841 | NOVARTIS PHARMACEUTICALS CANADA INC | ISOPTO CARPINE | Human | Yes | Prescription | 1 | PILOCARPINE HYDROCHLORIDE | 1 % |
Marketed | 00000868 | NOVARTIS PHARMACEUTICALS CANADA INC | ISOPTO CARPINE | Human | Yes | Prescription | 1 | PILOCARPINE HYDROCHLORIDE | 2 % |
Cancelled Post Market | 00000884 | NOVARTIS PHARMACEUTICALS CANADA INC | ISOPTO CARPINE | Human | Yes | Prescription | 1 | PILOCARPINE HYDROCHLORIDE | 4 % |
Marketed | 02457997 | NOVARTIS PHARMACEUTICALS CANADA INC | IZBA | Human | Yes | Prescription | 1 | TRAVOPROST | 0.003 % / W/V |
Marketed | 02452219 | NOVARTIS PHARMACEUTICALS CANADA INC | JADENU | Human | Yes | Prescription | 1 | DEFERASIROX | 90 MG |
Marketed | 02452227 | NOVARTIS PHARMACEUTICALS CANADA INC | JADENU | Human | Yes | Prescription | 1 | DEFERASIROX | 180 MG |
Marketed | 02452235 | NOVARTIS PHARMACEUTICALS CANADA INC | JADENU | Human | Yes | Prescription | 1 | DEFERASIROX | 360 MG |
Marketed | 02388006 | NOVARTIS PHARMACEUTICALS CANADA INC | JAKAVI | Human | Yes | Prescription | 1 | RUXOLITINIB (RUXOLITINIB PHOSPHATE) | 5 MG |
Marketed | 02388014 | NOVARTIS PHARMACEUTICALS CANADA INC | JAKAVI | Human | Yes | Prescription | 1 | RUXOLITINIB (RUXOLITINIB PHOSPHATE) | 15 MG |
Marketed | 02388022 | NOVARTIS PHARMACEUTICALS CANADA INC | JAKAVI | Human | Yes | Prescription | 1 | RUXOLITINIB (RUXOLITINIB PHOSPHATE) | 20 MG |
Marketed | 02434814 | NOVARTIS PHARMACEUTICALS CANADA INC | JAKAVI | Human | Yes | Prescription | 1 | RUXOLITINIB (RUXOLITINIB PHOSPHATE) | 10 MG |
Marketed | 02511355 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Schedule D | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Marketed | 02511355 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Prescription | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Approved | 02511363 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Prescription | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Approved | 02511363 | NOVARTIS PHARMACEUTICALS CANADA INC | KESIMPTA | Human | Yes | Schedule D | 1 | OFATUMUMAB | 20 MG / 0.4 ML |
Marketed | 02473569 | NOVARTIS PHARMACEUTICALS CANADA INC | KISQALI | Human | Yes | Prescription | 1 | RIBOCICLIB (RIBOCICLIB SUCCINATE) | 200 MG |
Marketed | 02480514 | NOVARTIS PHARMACEUTICALS CANADA INC | KYMRIAH | Human | Yes | Prescription | 1 | TISAGENLECLEUCEL | 600000000 CELLS |
Marketed | 02480514 | NOVARTIS PHARMACEUTICALS CANADA INC | KYMRIAH | Human | Yes | Schedule D | 1 | TISAGENLECLEUCEL | 600000000 CELLS |
Marketed | 02031094 | NOVARTIS PHARMACEUTICALS CANADA INC | LAMISIL | Human | Yes | Prescription | 1 | TERBINAFINE HYDROCHLORIDE | 1 % |
Marketed | 02031116 | NOVARTIS PHARMACEUTICALS CANADA INC | LAMISIL | Human | Yes | Prescription | 1 | TERBINAFINE (TERBINAFINE HYDROCHLORIDE) | 250 MG |
Marketed | 02238703 | NOVARTIS PHARMACEUTICALS CANADA INC | LAMISIL | Human | Yes | Prescription | 1 | TERBINAFINE HYDROCHLORIDE | 1 % / W/W |
Approved | 02239876 | NOVARTIS PHARMACEUTICALS CANADA INC | LAMISIL DERMGEL | Human | No | Prescription | 1 | TERBINAFINE | 10 MG / G |
Cancelled Post Market | 02128209 | NOVARTIS PHARMACEUTICALS CANADA INC | LENTARON | Human | No | Prescription | 2 | FORMESTANE | 250 MG / KIT |
Marketed | 02518376 | NOVARTIS PHARMACEUTICALS CANADA INC | LEQVIO | Human | Yes | Prescription | 1 | INCLISIRAN (INCLISIRAN SODIUM) | 284 MG / 1.5 ML |
Cancelled Post Market | 02061562 | NOVARTIS PHARMACEUTICALS CANADA INC | LESCOL 20MG | Human | Yes | Prescription | 1 | FLUVASTATIN (FLUVASTATIN SODIUM) | 20 MG |
Cancelled Post Market | 02061570 | NOVARTIS PHARMACEUTICALS CANADA INC | LESCOL 40MG | Human | Yes | Prescription | 1 | FLUVASTATIN (FLUVASTATIN SODIUM) | 40 MG |
Cancelled Post Market | 02250527 | NOVARTIS PHARMACEUTICALS CANADA INC | LESCOL XL | Human | Yes | Prescription | 1 | FLUVASTATIN (FLUVASTATIN SODIUM) | 80 MG |
Cancelled Post Market | 00636576 | NOVARTIS PHARMACEUTICALS CANADA INC | LIORESAL D.S. TAB 20MG | Human | Yes | Prescription | 1 | BACLOFEN | 20 MG |
Marketed | 02131048 | NOVARTIS PHARMACEUTICALS CANADA INC | LIORESAL INTRATHECAL 0.05MG/ML | Human | Yes | Prescription | 1 | BACLOFEN | 0.05 MG / ML |
Cancelled Post Market | 02131056 | NOVARTIS PHARMACEUTICALS CANADA INC | LIORESAL INTRATHECAL 0.5MG/ML | Human | Yes | Prescription | 1 | BACLOFEN | 0.5 MG / ML |
Cancelled Post Market | 02131064 | NOVARTIS PHARMACEUTICALS CANADA INC | LIORESAL INTRATHECAL 2MG/ML | Human | Yes | Prescription | 1 | BACLOFEN | 2 MG / ML |
Cancelled Post Market | 00455881 | NOVARTIS PHARMACEUTICALS CANADA INC | LIORESAL TAB 10MG | Human | Yes | Prescription | 1 | BACLOFEN | 10 MG |
Cancelled Post Market | 02131625 | NOVARTIS PHARMACEUTICALS CANADA INC | LIVOSTIN EYE DROPS | Human | Yes | Prescription | 1 | LEVOCABASTINE (LEVOCABASTINE HYDROCHLORIDE) | 0.5 MG / ML |
Cancelled Post Market | 00005134 | NOVARTIS PHARMACEUTICALS CANADA INC | LOCACORTEN .03% | Human | No | Prescription | 1 | FLUMETHASONE PIVALATE | .03 % |
Cancelled Post Market | 00074470 | NOVARTIS PHARMACEUTICALS CANADA INC | LOCACORTEN VIOFORM | Human | No | Prescription | 2 | FLUMETHASONE PIVALATE | .02 % |
Marketed | 02537117 | NOVARTIS PHARMACEUTICALS CANADA INC | LOCAMETZ | Radiopharmaceutical | Yes | Schedule C | 1 | GALLIUM (68Ga) GOZETOTIDE | 25 MCG / VIAL |
Cancelled Post Market | 00260568 | NOVARTIS PHARMACEUTICALS CANADA INC | LOCASALEN | Human | No | Prescription | 2 | SALICYLIC ACID | 3 % |
Cancelled Post Market | 00397431 | NOVARTIS PHARMACEUTICALS CANADA INC | LOPRESOR 100MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 100 MG |
Cancelled Post Market | 00397423 | NOVARTIS PHARMACEUTICALS CANADA INC | LOPRESOR 50MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 50 MG |
Cancelled Post Market | 00590819 | NOVARTIS PHARMACEUTICALS CANADA INC | LOPRESOR INJ 1.0MG/ML | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 1 MG / 1 ML |
Cancelled Post Market | 00658855 | NOVARTIS PHARMACEUTICALS CANADA INC | LOPRESOR SR 100MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 100 MG |
Cancelled Post Market | 00534560 | NOVARTIS PHARMACEUTICALS CANADA INC | LOPRESOR SR 200 MG | Human | Yes | Prescription | 1 | METOPROLOL TARTRATE | 200 MG |
Cancelled Post Market | 00885843 | NOVARTIS PHARMACEUTICALS CANADA INC | LOTENSIN 10MG | Human | Yes | Prescription | 1 | BENAZEPRIL HYDROCHLORIDE | 10 MG |
Cancelled Post Market | 00885851 | NOVARTIS PHARMACEUTICALS CANADA INC | LOTENSIN 20MG | Human | Yes | Prescription | 1 | BENAZEPRIL HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 00885835 | NOVARTIS PHARMACEUTICALS CANADA INC | LOTENSIN 5MG | Human | Yes | Prescription | 1 | BENAZEPRIL HYDROCHLORIDE | 5 MG |
Marketed | 02296810 | NOVARTIS PHARMACEUTICALS CANADA INC | LUCENTIS | Human | Yes | Prescription | 1 | RANIBIZUMAB | 10 MG / ML |
Marketed | 02296810 | NOVARTIS PHARMACEUTICALS CANADA INC | LUCENTIS | Human | Yes | Schedule D | 1 | RANIBIZUMAB | 10 MG / ML |
Marketed | 02425629 | NOVARTIS PHARMACEUTICALS CANADA INC | LUCENTIS | Human | Yes | Prescription | 1 | RANIBIZUMAB | 10 MG / ML |
Marketed | 02425629 | NOVARTIS PHARMACEUTICALS CANADA INC | LUCENTIS | Human | Yes | Schedule D | 1 | RANIBIZUMAB | 10 MG / ML |
Cancelled Post Market | 00641855 | NOVARTIS PHARMACEUTICALS CANADA INC | LUDIOMIL TAB 10MG | Human | No | Prescription | 1 | MAPROTILINE HYDROCHLORIDE | 10 MG |
Cancelled Post Market | 00360481 | NOVARTIS PHARMACEUTICALS CANADA INC | LUDIOMIL TAB 25MG | Human | No | Prescription | 1 | MAPROTILINE HYDROCHLORIDE | 25 MG / TAB |
Cancelled Post Market | 00360503 | NOVARTIS PHARMACEUTICALS CANADA INC | LUDIOMIL TAB 50MG | Human | No | Prescription | 1 | MAPROTILINE HYDROCHLORIDE | 50 MG / TAB |
Cancelled Post Market | 00360511 | NOVARTIS PHARMACEUTICALS CANADA INC | LUDIOMIL TAB 75MG | Human | No | Prescription | 1 | MAPROTILINE HYDROCHLORIDE | 75 MG / TAB |
Marketed | 02484552 | NOVARTIS PHARMACEUTICALS CANADA INC | LUTATHERA | Radiopharmaceutical | Yes | Schedule C | 1 | LUTETIUM (177LU) OXODOTREOTIDE | 370 MBq / ML |
Marketed | 02505851 | NOVARTIS PHARMACEUTICALS CANADA INC | LUXTURNA | Human | Yes | Schedule D | 1 | VORETIGENE NEPARVOVEC | 5000000000000 VG / ML |
Marketed | 02505851 | NOVARTIS PHARMACEUTICALS CANADA INC | LUXTURNA | Human | Yes | Prescription | 1 | VORETIGENE NEPARVOVEC | 5000000000000 VG / ML |
Marketed | 00042560 | NOVARTIS PHARMACEUTICALS CANADA INC | MAXIDEX | Human | Yes | Prescription | 1 | DEXAMETHASONE | 0.1 % / W/V |
Marketed | 00042579 | NOVARTIS PHARMACEUTICALS CANADA INC | MAXIDEX | Human | Yes | Prescription | 1 | DEXAMETHASONE | 0.1 % / W/W |
Marketed | 00042676 | NOVARTIS PHARMACEUTICALS CANADA INC | MAXITROL | Human | Yes | Prescription | 3 | DEXAMETHASONE | 0.1 % / W/V |
Marketed | 00358177 | NOVARTIS PHARMACEUTICALS CANADA INC | MAXITROL | Human | Yes | Prescription | 3 | DEXAMETHASONE | 0.1 % / W/W |
Marketed | 02496429 | NOVARTIS PHARMACEUTICALS CANADA INC | MAYZENT | Human | Yes | Prescription | 1 | SIPONIMOD | 0.25 MG |
Marketed | 02496437 | NOVARTIS PHARMACEUTICALS CANADA INC | MAYZENT | Human | Yes | Prescription | 1 | SIPONIMOD | 2 MG |
Approved | 02543370 | NOVARTIS PHARMACEUTICALS CANADA INC | MAYZENT | Human | Yes | Prescription | 1 | SIPONIMOD | 1 MG |
Marketed | 02409623 | NOVARTIS PHARMACEUTICALS CANADA INC | MEKINIST | Human | Yes | Prescription | 1 | TRAMETINIB | 0.5 MG |
Cancelled Pre Market | 02409631 | NOVARTIS PHARMACEUTICALS CANADA INC | MEKINIST | Human | Yes | Prescription | 1 | TRAMETINIB | 1 MG |
Marketed | 02409658 | NOVARTIS PHARMACEUTICALS CANADA INC | MEKINIST | Human | Yes | Prescription | 1 | TRAMETINIB | 2 MG |
Marketed | 02539993 | NOVARTIS PHARMACEUTICALS CANADA INC | MEKINIST | Human | Yes | Prescription | 1 | TRAMETINIB | 4.7 MG |
Cancelled Post Market | 00027359 | NOVARTIS PHARMACEUTICALS CANADA INC | MELLARIL | Human | No | Prescription | 1 | THIORIDAZINE HYDROCHLORIDE | 30 MG / ML |
Cancelled Post Market | 00027375 | NOVARTIS PHARMACEUTICALS CANADA INC | MELLARIL | Human | No | Prescription | 1 | THIORIDAZINE | 10 MG / 5 ML |
Cancelled Post Market | 00005622 | NOVARTIS PHARMACEUTICALS CANADA INC | METANDREN 10MG | Human | No | Schedule G (CDSA IV) | 1 | METHYLTESTOSTERONE | 10 MG / TAB |
Cancelled Post Market | 00005630 | NOVARTIS PHARMACEUTICALS CANADA INC | METANDREN 25MG | Human | No | Schedule G (CDSA IV) | 1 | METHYLTESTOSTERONE | 25 MG / TAB |
Approved | 02144301 | NOVARTIS PHARMACEUTICALS CANADA INC | MIACALCIN INJECTION 200IU/ML | Human | No | Prescription | 1 | CALCITONIN (SALMON SYNTHETIC) | 200 UNIT / ML |
Cancelled Post Market | 02240775 | NOVARTIS PHARMACEUTICALS CANADA INC | MIACALCIN NASAL SPRAY 200 IU | Human | Yes | Prescription | 1 | CALCITONIN (SALMON SYNTHETIC) | 200 UNIT / ACT |
Marketed | 02264560 | NOVARTIS PHARMACEUTICALS CANADA INC | MYFORTIC | Human | Yes | Prescription | 1 | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) | 180 MG |
Marketed | 02264579 | NOVARTIS PHARMACEUTICALS CANADA INC | MYFORTIC | Human | Yes | Prescription | 1 | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) | 360 MG |
Marketed | 02150662 | NOVARTIS PHARMACEUTICALS CANADA INC | NEORAL | Human | Yes | Prescription | 1 | CYCLOSPORINE | 50 MG |
Marketed | 02150670 | NOVARTIS PHARMACEUTICALS CANADA INC | NEORAL | Human | Yes | Prescription | 1 | CYCLOSPORINE | 100 MG |
Marketed | 02150689 | NOVARTIS PHARMACEUTICALS CANADA INC | NEORAL | Human | Yes | Prescription | 1 | CYCLOSPORINE | 25 MG |
Marketed | 02150697 | NOVARTIS PHARMACEUTICALS CANADA INC | NEORAL | Human | Yes | Prescription | 1 | CYCLOSPORINE | 100 MG / ML |
Marketed | 02237671 | NOVARTIS PHARMACEUTICALS CANADA INC | NEORAL | Human | Yes | Prescription | 1 | CYCLOSPORINE | 10 MG |
Marketed | 02490005 | NOVARTIS PHARMACEUTICALS CANADA INC | NETSPOT | Radiopharmaceutical | Yes | Schedule C | 1 | OXODOTREOTIDE | 40 MCG / VIAL |
Marketed | 02308983 | NOVARTIS PHARMACEUTICALS CANADA INC | NEVANAC | Human | Yes | Prescription | 1 | NEPAFENAC | 0.1 % / W/V |
Cancelled Post Market | 02376938 | NOVARTIS PHARMACEUTICALS CANADA INC | ONBREZ BREEZHALER | Human | Yes | Prescription | 1 | INDACATEROL (INDACATEROL MALEATE) | 75 MCG |
Cancelled Post Market | 00568643 | NOVARTIS PHARMACEUTICALS CANADA INC | PARLODEL CAP 5MG | Human | No | Prescription | 1 | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) | 5 MG |
Cancelled Post Market | 00371033 | NOVARTIS PHARMACEUTICALS CANADA INC | PARLODEL TAB 2.5MG | Human | Yes | Prescription | 1 | BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) | 2.5 MG |
Marketed | 02362171 | NOVARTIS PHARMACEUTICALS CANADA INC | PATADAY | Human | Yes | Prescription | 1 | OLOPATADINE (OLOPATADINE HYDROCHLORIDE) | 0.2 % / W/V |
Marketed | 02233143 | NOVARTIS PHARMACEUTICALS CANADA INC | PATANOL | Human | Yes | Prescription | 1 | OLOPATADINE (OLOPATADINE HYDROCHLORIDE) | 0.1 % / W/V |
Marketed | 02458551 | NOVARTIS PHARMACEUTICALS CANADA INC | PAZEO | Human | Yes | Prescription | 1 | OLOPATADINE (OLOPATADINE HYDROCHLORIDE) | 0.7 % / W/V |
Cancelled Post Market | 00010448 | NOVARTIS PHARMACEUTICALS CANADA INC | PERTOFRANE 25MG | Human | No | Prescription | 1 | DESIPRAMINE HYDROCHLORIDE | 25 MG / TAB |
Approved | 02497042 | NOVARTIS PHARMACEUTICALS CANADA INC | PIQRAY | Human | Yes | Prescription | 1 | ALPELISIB | 50 MG |
Marketed | 02497069 | NOVARTIS PHARMACEUTICALS CANADA INC | PIQRAY | Human | Yes | Prescription | 1 | ALPELISIB | 150 MG |
Marketed | 02497077 | NOVARTIS PHARMACEUTICALS CANADA INC | PIQRAY | Human | Yes | Prescription | 1 | ALPELISIB | 200 MG |
Marketed | 02497085 | NOVARTIS PHARMACEUTICALS CANADA INC | PIQRAY | Human | Yes | Prescription | 2 | ALPELISIB | 50 MG |
Marketed | 02530198 | NOVARTIS PHARMACEUTICALS CANADA INC | PLUVICTO | Radiopharmaceutical | Yes | Schedule C | 1 | LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN | 1000 MBq / ML |
Cancelled Post Market | 00027596 | NOVARTIS PHARMACEUTICALS CANADA INC | POTASSIUM-NOVARTIS | Human | No | OTC | 2 | POTASSIUM CHLORIDE | 600 MG / EVT |
Marketed | 02361825 | NOVARTIS PHARMACEUTICALS CANADA INC | REVOLADE | Human | Yes | Prescription | 1 | ELTROMBOPAG (ELTROMBOPAG OLAMINE) | 25 MG |
Marketed | 02361833 | NOVARTIS PHARMACEUTICALS CANADA INC | REVOLADE | Human | Yes | Prescription | 1 | ELTROMBOPAG (ELTROMBOPAG OLAMINE) | 50 MG |
Cancelled Pre Market | 02423049 | NOVARTIS PHARMACEUTICALS CANADA INC | REVOLADE | Human | Yes | Prescription | 1 | ELTROMBOPAG (ELTROMBOPAG OLAMINE) | 75 MG |
Cancelled Pre Market | 02461382 | NOVARTIS PHARMACEUTICALS CANADA INC | REVOLADE | Human | Yes | Prescription | 1 | ELTROMBOPAG (ELTROMBOPAG OLAMINE) | 12.5 MG |
Cancelled Post Market | 00005606 | NOVARTIS PHARMACEUTICALS CANADA INC | RITALIN 10MG | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 10 MG |
Cancelled Post Market | 00005614 | NOVARTIS PHARMACEUTICALS CANADA INC | RITALIN 20MG | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 00632775 | NOVARTIS PHARMACEUTICALS CANADA INC | RITALIN-SR TAB 20MG | Human | Yes | Schedule G (CDSA III) | 1 | METHYLPHENIDATE HYDROCHLORIDE | 20 MG |
Cancelled Post Market | 00005193 | NOVARTIS PHARMACEUTICALS CANADA INC | ROGITINE 5MG/VIAL | Human | No | Prescription | 1 | PHENTOLAMINE MESYLATE | 5 MG / AMP |
Marketed | 02466236 | NOVARTIS PHARMACEUTICALS CANADA INC | RYDAPT | Human | Yes | Prescription | 1 | MIDOSTAURIN | 25 MG |
Approved | 02549018 | NOVARTIS PHARMACEUTICALS CANADA INC | SACUBITRIL-VALSARTAN | Human | Yes | Prescription | 2 | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) | 24 MG |
Approved | 02549026 | NOVARTIS PHARMACEUTICALS CANADA INC | SACUBITRIL-VALSARTAN | Human | Yes | Prescription | 2 | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) | 49 MG |
Approved | 02549034 | NOVARTIS PHARMACEUTICALS CANADA INC | SACUBITRIL-VALSARTAN | Human | Yes | Prescription | 2 | SACUBITRIL (SACUBITRIL VALSARTAN SODIUM HYDRATE COMPLEX) | 97 MG |
Marketed | 00593257 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDIMMUNE I.V. | Human | Yes | Prescription | 1 | CYCLOSPORINE | 50 MG / ML |
Marketed | 00839191 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 50 MCG / ML |
Cancelled Post Market | 00839205 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 100 MCG / ML |
Cancelled Post Market | 00839213 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 500 MCG / ML |
Cancelled Post Market | 02049392 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 200 MCG / ML |
Marketed | 02239323 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN LAR | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 10 MG / VIAL |
Marketed | 02239324 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN LAR | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 20 MG / VIAL |
Marketed | 02239325 | NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN LAR | Human | Yes | Prescription | 1 | OCTREOTIDE (OCTREOTIDE ACETATE) | 30 MG / VIAL |
Cancelled Post Market | 00027499 | NOVARTIS PHARMACEUTICALS CANADA INC | SANSERT | Human | No | Prescription | 1 | METHYSERGIDE MALEATE | 2 MG |
Marketed | 02528320 | NOVARTIS PHARMACEUTICALS CANADA INC | SCEMBLIX | Human | Yes | Prescription | 1 | ASCIMINIB (ASCIMINIB HYDROCHLORIDE) | 20 MG |
Marketed | 02528339 | NOVARTIS PHARMACEUTICALS CANADA INC | SCEMBLIX | Human | Yes | Prescription | 1 | ASCIMINIB (ASCIMINIB HYDROCHLORIDE) | 40 MG |
Cancelled Post Market | 02288389 | NOVARTIS PHARMACEUTICALS CANADA INC | SEBIVO | Human | Yes | Prescription | 1 | TELBIVUDINE | 600 MG |
Marketed | 02394936 | NOVARTIS PHARMACEUTICALS CANADA INC | SEEBRI BREEZHALER | Human | Yes | Prescription | 1 | GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) | 50 MCG |
Cancelled Post Market | 00074608 | NOVARTIS PHARMACEUTICALS CANADA INC | SER-AP-ES TAB | Human | No | Prescription | 3 | RESERPINE | 0.1 MG |
Cancelled Post Market | 00027448 | NOVARTIS PHARMACEUTICALS CANADA INC | SERENTIL TAB 10MG | Human | No | Prescription | 1 | MESORIDAZINE (MESORIDAZINE BESYLATE) | 10 MG / TAB |
Cancelled Post Market | 00027456 | NOVARTIS PHARMACEUTICALS CANADA INC | SERENTIL TAB 25MG | Human | No | Prescription | 1 | MESORIDAZINE (MESORIDAZINE BESYLATE) | 25 MG / TAB |
Cancelled Post Market | 00027464 | NOVARTIS PHARMACEUTICALS CANADA INC | SERENTIL TAB 50MG | Human | No | Prescription | 1 | MESORIDAZINE (MESORIDAZINE BESYLATE) | 50 MG / TAB |
Cancelled Post Market | 00005665 | NOVARTIS PHARMACEUTICALS CANADA INC | SERPASIL 0.25MG | Human | No | Prescription | 1 | RESERPINE | 0.25 MG / TAB |
Marketed | 02435411 | NOVARTIS PHARMACEUTICALS CANADA INC | SIMBRINZA | Human | Yes | Prescription | 2 | BRINZOLAMIDE | 1 % / W/V |
Marketed | 02242815 | NOVARTIS PHARMACEUTICALS CANADA INC | SIMULECT | Human | Yes | Prescription | 1 | BASILIXIMAB | 20 MG / VIAL |
Marketed | 02242815 | NOVARTIS PHARMACEUTICALS CANADA INC | SIMULECT | Human | Yes | Schedule D | 1 | BASILIXIMAB | 20 MG / VIAL |
Cancelled Post Market | 00074225 | NOVARTIS PHARMACEUTICALS CANADA INC | SLOW K | Human | Yes | Ethical | 1 | POTASSIUM CHLORIDE | 600 MG |
Cancelled Post Market | 00534587 | NOVARTIS PHARMACEUTICALS CANADA INC | SLOW TRASICOR TAB 160MG | Human | No | Prescription | 1 | OXPRENOLOL HYDROCHLORIDE | 160 MG / TAB |
Cancelled Post Market | 00534579 | NOVARTIS PHARMACEUTICALS CANADA INC | SLOW TRASICOR TAB 80MG | Human | No | Prescription | 1 | OXPRENOLOL HYDROCHLORIDE | 80 MG / TAB |
Cancelled Post Market | 02245439 | NOVARTIS PHARMACEUTICALS CANADA INC | STARLIX 120MG | Human | Yes | Prescription | 1 | NATEGLINIDE | 120 MG |
Cancelled Post Market | 02245440 | NOVARTIS PHARMACEUTICALS CANADA INC | STARLIX 180MG | Human | Yes | Prescription | 1 | NATEGLINIDE | 180 MG |
Cancelled Post Market | 02245438 | NOVARTIS PHARMACEUTICALS CANADA INC | STARLIX 60MG | Human | Yes | Prescription | 1 | NATEGLINIDE | 60 MG |
Marketed | 02527391 | NOVARTIS PHARMACEUTICALS CANADA INC | TABRECTA | Human | Yes | Prescription | 1 | CAPMATINIB (CAPMATINIB HYDROCHLORIDE) | 150 MG |
Marketed | 02527405 | NOVARTIS PHARMACEUTICALS CANADA INC | TABRECTA | Human | Yes | Prescription | 1 | CAPMATINIB (CAPMATINIB HYDROCHLORIDE) | 200 MG |
Marketed | 02409607 | NOVARTIS PHARMACEUTICALS CANADA INC | TAFINLAR | Human | Yes | Prescription | 1 | DABRAFENIB (DABRAFENIB MESYLATE) | 50 MG |
Marketed | 02409615 | NOVARTIS PHARMACEUTICALS CANADA INC | TAFINLAR | Human | Yes | Prescription | 1 | DABRAFENIB (DABRAFENIB MESYLATE) | 75 MG |
Marketed | 02540053 | NOVARTIS PHARMACEUTICALS CANADA INC | TAFINLAR | Human | Yes | Prescription | 1 | DABRAFENIB (DABRAFENIB MESYLATE) | 10 MG |
Marketed | 02315874 | NOVARTIS PHARMACEUTICALS CANADA INC | TASIGNA | Human | Yes | Prescription | 1 | NILOTINIB (NILOTINIB HYDROCHLORIDE MONOHYDRATE) | 200 MG |
Marketed | 02368250 | NOVARTIS PHARMACEUTICALS CANADA INC | TASIGNA | Human | Yes | Prescription | 1 | NILOTINIB (NILOTINIB HYDROCHLORIDE MONOHYDRATE) | 150 MG |
Cancelled Post Market | 02481715 | NOVARTIS PHARMACEUTICALS CANADA INC | TASIGNA | Human | Yes | Prescription | 1 | NILOTINIB (NILOTINIB HYDROCHLORIDE MONOHYDRATE) | 50 MG |
Marketed | 00010405 | NOVARTIS PHARMACEUTICALS CANADA INC | TEGRETOL | Human | Yes | Prescription | 1 | CARBAMAZEPINE | 200 MG |
Cancelled Post Market | 00369810 | NOVARTIS PHARMACEUTICALS CANADA INC | TEGRETOL CHEWTABS 100 MG | Human | Yes | Prescription | 1 | CARBAMAZEPINE | 100 MG |
Cancelled Post Market | 00665088 | NOVARTIS PHARMACEUTICALS CANADA INC | TEGRETOL CHEWTABS 200 MG | Human | Yes | Prescription | 1 | CARBAMAZEPINE | 200 MG |
Marketed | 00755583 | NOVARTIS PHARMACEUTICALS CANADA INC | TEGRETOL CR | Human | Yes | Prescription | 1 | CARBAMAZEPINE | 400 MG |
Marketed | 00773611 | NOVARTIS PHARMACEUTICALS CANADA INC | TEGRETOL CR | Human | Yes | Prescription | 1 | CARBAMAZEPINE | 200 MG |
Marketed | 02194333 | NOVARTIS PHARMACEUTICALS CANADA INC | TEGRETOL SUSPENSION | Human | Yes | Prescription | 1 | CARBAMAZEPINE | 100 MG / 5 ML |
Marketed | 00778907 | NOVARTIS PHARMACEUTICALS CANADA INC | TOBRADEX | Human | Yes | Prescription | 2 | TOBRAMYCIN | 0.3 % / W/V |
Marketed | 00778915 | NOVARTIS PHARMACEUTICALS CANADA INC | TOBRADEX | Human | Yes | Prescription | 2 | TOBRAMYCIN | 0.3 % / W/W |
Marketed | 00513962 | NOVARTIS PHARMACEUTICALS CANADA INC | TOBREX | Human | Yes | Prescription | 1 | TOBRAMYCIN | 0.3 % / W/V |
Marketed | 00614254 | NOVARTIS PHARMACEUTICALS CANADA INC | TOBREX | Human | Yes | Prescription | 1 | TOBRAMYCIN | 0.3 % / W/W |
Cancelled Pre Market | 02261243 | NOVARTIS PHARMACEUTICALS CANADA INC | TOBREXAN | Human | Yes | Prescription | 1 | TOBRAMYCIN | 0.3 % / W/V |
Cancelled Post Market | 00010464 | NOVARTIS PHARMACEUTICALS CANADA INC | TOFRANIL 10MG | Human | No | Prescription | 1 | IMIPRAMINE HYDROCHLORIDE | 10 MG |
Cancelled Post Market | 00010472 | NOVARTIS PHARMACEUTICALS CANADA INC | TOFRANIL 25MG | Human | Yes | Prescription | 1 | IMIPRAMINE HYDROCHLORIDE | 25 MG |
Cancelled Post Market | 00010480 | NOVARTIS PHARMACEUTICALS CANADA INC | TOFRANIL 50MG | Human | Yes | Prescription | 1 | IMIPRAMINE HYDROCHLORIDE | 50 MG |
Cancelled Post Market | 00306487 | NOVARTIS PHARMACEUTICALS CANADA INC | TOFRANIL 75MG | Human | Yes | Prescription | 1 | IMIPRAMINE HYDROCHLORIDE | 75 MG |
Cancelled Post Market | 00584223 | NOVARTIS PHARMACEUTICALS CANADA INC | TRANSDERM-NITRO 0.2 | Human | Yes | Ethical | 1 | NITROGLYCERIN | 0.2 MG / HOUR |
Cancelled Post Market | 00852384 | NOVARTIS PHARMACEUTICALS CANADA INC | TRANSDERM-NITRO 0.4 | Human | Yes | Ethical | 1 | NITROGLYCERIN | 0.4 MG / HOUR |
Cancelled Post Market | 02046156 | NOVARTIS PHARMACEUTICALS CANADA INC | TRANSDERM-NITRO 0.6 | Human | Yes | Ethical | 1 | NITROGLYCERIN | 0.6 MG / HOUR |
Cancelled Post Market | 02046164 | NOVARTIS PHARMACEUTICALS CANADA INC | TRANSDERM-NITRO 0.8 | Human | No | Ethical | 1 | NITROGLYCERIN | 100 MG / SRD |
Cancelled Post Market | 00402567 | NOVARTIS PHARMACEUTICALS CANADA INC | TRASICOR TAB 20MG | Human | No | Prescription | 1 | OXPRENOLOL HYDROCHLORIDE | 20 MG / TAB |
Cancelled Post Market | 00402575 | NOVARTIS PHARMACEUTICALS CANADA INC | TRASICOR TAB 40MG | Human | No | Prescription | 1 | OXPRENOLOL HYDROCHLORIDE | 40 MG |
Cancelled Post Market | 00402583 | NOVARTIS PHARMACEUTICALS CANADA INC | TRASICOR TAB 80MG | Human | No | Prescription | 1 | OXPRENOLOL HYDROCHLORIDE | 80 MG |
Marketed | 02318008 | NOVARTIS PHARMACEUTICALS CANADA INC | TRAVATAN Z | Human | Yes | Prescription | 1 | TRAVOPROST | 0.004 % / W/V |
Marketed | 02368676 | NOVARTIS PHARMACEUTICALS CANADA INC | TRIESENCE | Human | Yes | Prescription | 1 | TRIAMCINOLONE ACETONIDE | 40 MG / ML |
Cancelled Post Market | 02242067 | NOVARTIS PHARMACEUTICALS CANADA INC | TRILEPTAL 150 MG | Human | Yes | Prescription | 1 | OXCARBAZEPINE | 150 MG |
Marketed | 02242068 | NOVARTIS PHARMACEUTICALS CANADA INC | TRILEPTAL 300 MG | Human | Yes | Prescription | 1 | OXCARBAZEPINE | 300 MG |
Marketed | 02242069 | NOVARTIS PHARMACEUTICALS CANADA INC | TRILEPTAL 600 MG | Human | Yes | Prescription | 1 | OXCARBAZEPINE | 600 MG |
Marketed | 02244673 | NOVARTIS PHARMACEUTICALS CANADA INC | TRILEPTAL ORAL SUSPENSION | Human | Yes | Prescription | 1 | OXCARBAZEPINE | 60 MG / ML |
Marketed | 02326442 | NOVARTIS PHARMACEUTICALS CANADA INC | TYKERB | Human | Yes | Prescription | 1 | LAPATINIB (LAPATINIB DITOSYLATE) | 250 MG |
Marketed | 02418282 | NOVARTIS PHARMACEUTICALS CANADA INC | ULTIBRO BREEZHALER | Human | Yes | Prescription | 2 | GLYCOPYRRONIUM (GLYCOPYRRONIUM BROMIDE) | 50 MCG |
Marketed | 02252260 | NOVARTIS PHARMACEUTICALS CANADA INC | VIGAMOX | Human | Yes | Prescription | 1 | MOXIFLOXACIN (MOXIFLOXACIN HYDROCHLORIDE) | 0.5 % |
Cancelled Post Market | 00005142 | NOVARTIS PHARMACEUTICALS CANADA INC | VIOFORM 3% | Human | No | OTC | 1 | CLIOQUINOL | 3 % |
Cancelled Post Market | 00005797 | NOVARTIS PHARMACEUTICALS CANADA INC | VIOFORM 3% | Human | No | OTC | 1 | CLIOQUINOL | 3 % |
Cancelled Post Market | 00074489 | NOVARTIS PHARMACEUTICALS CANADA INC | VIOFORM HYDROCORTISONE MILD | Human | No | OTC | 2 | CLIOQUINOL | 3 % |
Cancelled Post Market | 02204444 | NOVARTIS PHARMACEUTICALS CANADA INC | VIVELLE 100MCG | Human | No | Prescription | 1 | ESTRADIOL | 8.66 MG |
Cancelled Post Market | 02204401 | NOVARTIS PHARMACEUTICALS CANADA INC | VIVELLE 37.5MCG | Human | No | Prescription | 1 | ESTRADIOL | 3.28 MG |
Cancelled Post Market | 02204428 | NOVARTIS PHARMACEUTICALS CANADA INC | VIVELLE 50MCG | Human | No | Prescription | 1 | ESTRADIOL | 4.33 MG |
Cancelled Post Market | 02204436 | NOVARTIS PHARMACEUTICALS CANADA INC | VIVELLE 75MCG | Human | No | Prescription | 1 | ESTRADIOL | 6.56 MG |
Cancelled Post Market | 00514012 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 50 MG |
Marketed | 00632724 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 50 MG |
Cancelled Post Market | 00632732 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 100 MG |
Marketed | 01940414 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN OPHTHA | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 0.1 % / W/V |
Marketed | 00881635 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN RAPIDE | Human | Yes | Prescription | 1 | DICLOFENAC POTASSIUM | 50 MG |
Marketed | 00590827 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN SR | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 100 MG |
Cancelled Post Market | 00782459 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN SR | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 75 MG |
Cancelled Post Market | 00514004 | NOVARTIS PHARMACEUTICALS CANADA INC | VOLTAREN TAB 25MG | Human | Yes | Prescription | 1 | DICLOFENAC SODIUM | 25 MG |
Marketed | 02352303 | NOVARTIS PHARMACEUTICALS CANADA INC | VOTRIENT | Human | Yes | Prescription | 1 | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) | 200 MG |
Cancelled Pre Market | 02352311 | NOVARTIS PHARMACEUTICALS CANADA INC | VOTRIENT | Human | Yes | Prescription | 1 | PAZOPANIB (PAZOPANIB HYDROCHLORIDE) | 400 MG |
Marketed | 02260565 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / VIAL |
Marketed | 02260565 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / VIAL |
Marketed | 02459787 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
Marketed | 02459787 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
Marketed | 02459795 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / 1 ML |
Marketed | 02459795 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / 1 ML |
Marketed | 02545136 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
Marketed | 02545136 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 75 MG / 0.5 ML |
Marketed | 02545144 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 150 MG / 1 ML |
Marketed | 02545144 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 150 MG / 1 ML |
Approved | 02545152 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 300 MG / 2 ML |
Approved | 02545152 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 300 MG / 2 ML |
Approved | 02545160 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Prescription | 1 | OMALIZUMAB | 300 MG / 2 ML |
Approved | 02545160 | NOVARTIS PHARMACEUTICALS CANADA INC | XOLAIR | Human | Yes | Schedule D | 1 | OMALIZUMAB | 300 MG / 2 ML |
Approved | 02172585 | NOVARTIS PHARMACEUTICALS CANADA INC | ZADITEN - DPS 1MG/ML | Human | No | Prescription | 1 | KETOTIFEN (KETOTIFEN FUMARATE) | 1 MG / ML |
Cancelled Post Market | 02279223 | NOVARTIS PHARMACEUTICALS CANADA INC | ZADITOR | Human | Yes | Prescription | 1 | KETOTIFEN (KETOTIFEN FUMARATE) | 0.25 MG / ML |
Cancelled Post Market | 02213567 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOFRAN | Human | Yes | Prescription | 1 | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 4 MG |
Cancelled Post Market | 02213575 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOFRAN | Human | Yes | Prescription | 1 | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 8 MG |
Cancelled Post Market | 02213745 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOFRAN | Human | Yes | Prescription | 1 | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 2 MG / ML |
Cancelled Post Market | 02229639 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOFRAN | Human | Yes | Prescription | 1 | ONDANSETRON (ONDANSETRON HYDROCHLORIDE DIHYDRATE) | 4 MG / 5 ML |
Marketed | 02509695 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOLGENSMA | Human | Yes | Schedule D | 1 | ONASEMNOGENE ABEPARVOVEC | 20000000000000 VG / ML |
Marketed | 02509695 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOLGENSMA | Human | Yes | Prescription | 1 | ONASEMNOGENE ABEPARVOVEC | 20000000000000 VG / ML |
Marketed | 02248296 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOMETA CONCENTRATE | Human | Yes | Prescription | 1 | ZOLEDRONIC ACID (ZOLEDRONIC ACID MONOHYDRATE) | 4 MG / 5 ML |
Cancelled Post Market | 02242725 | NOVARTIS PHARMACEUTICALS CANADA INC | ZOMETA LYOPHILIZED POWDER | Human | Yes | Prescription | 1 | ZOLEDRONIC ACID (ZOLEDRONIC ACID MONOHYDRATE) | 4 MG / VIAL |
Marketed | 02436779 | NOVARTIS PHARMACEUTICALS CANADA INC | ZYKADIA | Human | Yes | Prescription | 1 | CERITINIB | 150 MG |
Application information
Related information
Contact us
Version 4.0.3